MITAPIVAT (mye ta PIV at) treats hemolytic anemia caused by pyruvate kinase deficiency. It works by stopping red blood cells from breaking down too quickly. This decreases symptoms and the need for blood transfusions.


PYRUKYND Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.